Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
NCT05597709 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2900
Last updated 2022-10-28
Summary
In 2019, the number of patients with diabetes was about 463 million in the world, accounting for 8.3% of the total population, and it is expected to rise to 578 million (9.2%) by 2030 and 700 million (9.6%) by 2045. According to the WHO diagnostic criteria, the prevalence of diabetes among adults in China from 2015 to 2017 was 11.2%, of which over 90% were type 2 diabetes mellitus (T2DM). The global prevalence of non-alcoholic fatty liver disease (NAFLD) is also very high, which was approximately 25% in 2016. The prevalence of NAFLD may continue to rise. NAFLD is often accompanied by clinical manifestations of metabolic syndrome, such as obesity, T2DM, hyperlipidemia and hypertension.
Conditions
- Type 2 Diabetes Mellitus in Remission
- Metabolic Associated Fatty Liver Disease
Interventions
- PROCEDURE
-
Ultrasound attenuation parameter measurement, fasting blood glucose and fasting insulin determination
Eligible participants will receive ultrasound attenuation parameter with iLivTouch, fasting blood glucose and fasting insulin determination
Sponsors & Collaborators
-
Zhongda Hospital
collaborator OTHER -
Suzhou Municipal Hospital
collaborator OTHER -
Suzhou Fifth People's Hospital
collaborator UNKNOWN -
Xuzhou Mining Group General Hospital
collaborator UNKNOWN -
Nantong First People's Hospital
collaborator OTHER -
Changzhou Second People's Hospital
collaborator UNKNOWN -
Huaian Second People's Hospital
collaborator UNKNOWN -
Huaian Hospital
collaborator UNKNOWN -
Taizhou Jiangyan Traditional Chinese Medicine Hospital
collaborator UNKNOWN -
Yangzhou Jiangdu People's Hospital
collaborator UNKNOWN -
Huaian Xuyi County People's Hospital
collaborator UNKNOWN -
Wuxi Hisky Medical Technology Co Ltd
lead INDUSTRY
Principal Investigators
-
Ling Li, Professor · Zhongda Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2023-06-01
- Completion
- 2027-06-01
Countries
- China
Study Locations
More Related Trials
-
Comprehensive Awareness and Control in Diabetes Patients in China Jiangxi: A Cross-Sectional Survey
NCT03363360 ·Status: UNKNOWN
-
Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes
NCT03525769 ·Status: RECRUITING
-
The Risk Factors of Cardiovascular Disease in Elderly Diabetic Patients: A Prospective Cohort Study
NCT04544527 ·Status: RECRUITING
-
A Prospective Cohort Study for Establishing Clinical Excellence in Patients With Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes
NCT05401708 ·Status: NOT_YET_RECRUITING
-
10-year Risk Prediction Models of Complications and Mortality of DM in Hong Kong
NCT03299010 ·Status: COMPLETED
-
The Effect of Remote SMBG Combined With the Application of APP on the Improvement of T2DM Management in the Community
NCT03588000 ·Status: COMPLETED ·Phase: NA
-
Chinese Endocrinologists Health Education Study
NCT05715307 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Precise Treatment of Prediabetes and Stage 1 Hypertension
NCT04529590 ·Status: COMPLETED
-
Correlation of Xanthelasma With Atherosclerosis, Hepatic Fat and Fibrosis
NCT05945030 ·Status: UNKNOWN
-
A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China
NCT01307410 ·Status: UNKNOWN
-
China Diabetes Registry by Metabolic Management Center
NCT03811470 ·Status: RECRUITING
-
Study on Adherence to a Mediterranean Diet in a Population of Patients With Type 2 Diabetes
NCT05292833 ·Status: COMPLETED
-
An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients
NCT01360697 ·Status: UNKNOWN ·Phase: NA
-
HbA1c Prediction Model in Patients With Type 2 Diabetes
NCT05824286 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Relevant Influencing Factors of Glycemic Control in Patients With Diabetes
NCT05854862 ·Status: UNKNOWN
-
The Effect and Mechanism of MMP-9 in Inducing Atherosclerosis
NCT04424706 ·Status: UNKNOWN
-
Observational Study of ASCVD Risks of Type 2 Diabetes in East China
NCT04866667 ·Status: COMPLETED
-
A Multicenter Cross-sectional Study of Shear Wave Ultrasound Imaging in Evaluating Supraspinatus Tendon Elasticity
NCT05769712 ·Status: UNKNOWN
-
Correlation Between Targeted HbA1c Values and Prevention of Recurrent Cardiovascular Events in Type 2 Diabetes After PCI
NCT05134129 ·Status: UNKNOWN
-
Early Diagnosis of Diabetes Mellitus Type 2 (DM2)
NCT00469287 ·Status: COMPLETED
-
An Epidemiological and Long-Term Endpoint Registry Study on Disease-Syndrome Correlation Patterns in Comorbid Population With Diabetes and Ischemic Cardio-Cerebrovascular Disease
NCT07104422 ·Status: NOT_YET_RECRUITING
-
Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure
NCT03206593 ·Status: UNKNOWN
-
Metabolic Phenotypes of Obesity and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
NCT06591104 ·Status: NOT_YET_RECRUITING
-
Nationwide Assessment of Cardiovascular Risk Factors: in Chinese Patients With Type 2 Diabetes
NCT01128205 ·Status: COMPLETED
-
The Prevalence of Metabolic Syndrome and Its Associated Factors in an Urban City
NCT00308672 ·Status: UNKNOWN